Skip to content
Open access

Development and validation of an interpretable machine learning model for pulmonary heart disease in patients with pneumoconiosis

Sep 2026 · Frontiers in Public Health · Vol 14 · 0 citations · 36 references
Medicine

TL;DR

A machine learning model based on routinely available data is developed and validated to support early risk stratification and clinical decision-making in resource-limited environments and indicates that machine learning models, particularly LR, may be useful for PHD risk screening and stratification among patients with pneumoconiosis.

Abstract

Background Pneumoconiosis patients with pulmonary heart disease (PHD) face an elevated risk of mortality. Early identification of individuals at higher risk of PHD is important for timely risk stratification and clinical management. However, few risk-screening models have been specifically developed for pneumoconiosis in primary care settings, where access to advanced diagnostic resources may be limited. Therefore, this study developed and validated a machine learning model based on routinely available data to support early risk stratification and clinical decision-making in resource-limited environments. Method A dual-design occupational pneumoconiosis cohort, comprising retrospective and prospective components, was established using occupational, epidemiological, and laboratory data obtained from electronic medical records and questionnaires. Key variables were selected using least absolute shrinkage and selection operator (LASSO) regression; five machine learning models were developed using five-fold cross-validation with grid search for hyperparameter tuning. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), F1 score, accuracy, precision-recall area under the curve (PR AUC), calibration metrics, and threshold analysis. The prospective cohort was used to evaluate the generalizability of the models. Model interpretability was assessed by Shapley additive explanations (SHAP). Results Following strict application of the inclusion and exclusion criteria, the retrospective cohort included 984 hospitalized patients (2012–2021), whereas the prospective cohort comprised 829 patients enrolled since 2021. LASSO identified 10 variables for model construction. All models demonstrated satisfactory discrimination, with logistic regression (LR) achieving an AUC of 0.816 in the external validation cohort. Lower BMI, albumin, and platelet large cell ratio (P-LCR), as well as higher red blood cell distribution width coefficient of variation (RDW-CV), older age, and stage III pneumoconiosis, were associated with higher predicted risk of PHD. The SHAP interaction network further indicated prominent statistical interaction patterns among hematological abnormalities, nutritional status, and disease severity, based on their joint contributions to model predictions. Conclusion This study indicates that machine learning models, particularly LR, may be useful for PHD risk screening and stratification among patients with pneumoconiosis. SHAP analysis identified clinically accessible variables that were important for model predictions, indicating a multidimensional pattern of associations across hematological, nutritional, and disease-severity domains.

Read PDF

Similar papers

Sep 2026

Construction and evaluation of a machine-learning-based prediction model for pneumonia in patients with acute leukemia.

An interpretable XGBoost model that accurately predicts pneumonia risk in AL patients based on routine admission data is developed and validated and provides actionable risk stratification to inform preemptive diagnostic and therapeutic strategies.

W. Zhuang, Chen Huang, Xu-Dong Ma et al. · 0 citations
Open access Jan 2026

Development and validation of an explainable machine learning model for risk stratification in patients with clinically suspected acute pulmonary embolism: retrospective study

A machine learning model predicts acute pulmonary embolism risk in suspected patients to reduce unnecessary CTPA overuse and radiation exposure and provides interpretable explanations for individual risk predictions.

Qing-Ming Li, Hui-Jun Qin, Jian Xu · 0 citations
Sep 2026

Interpretable Machine Learning for In-Hospital Mortality Prediction in Patients With Diabetes and ARDS: Development and External Validation.

Logistic Regression showed potential as an interpretable early ICU risk-stratification tool and externally validated machine learning models for in-hospital mortality prediction in patients with diabetes and ARDS.

Ya-Lin Dong, Meng-Xue Hou, Qian-Qian Wang et al. · 0 citations
Open access Sep 2026

Time-Series modeling for predicting mortality risk in intensive care unit patients with pulmonary inflammation

Objective This study aims to evaluate dynamic changes in pneumonia-related mortality risk among ICU patients using time-series models and develop interpretable predictive models for early mortality assessment. Methods Data were obtained from the MIMIC-IV and eICU Collaborative Research Database. The MIMIC-IV cohort was...

Yi-Hai Zhai, Rui-Xin-Xu-Rui-Xin Xu, Hai-Su Lu et al. · 0 citations
Open access Aug 2026

Development and validation of an explainable XGBoost model for early mortality prediction in pediatric sepsis

Objective To develop and internally validate an explainable machine learning model for early mortality prediction in pediatric sepsis using routinely available clinical variables, to support clinical risk stratification and decision-making. Methods A total of 752 children with sepsis admitted to the Pediatric Intensive...

Hong-Mei Chen, Li-Nong Wang, Yan-Bing Fu et al. · 0 citations
Open access Sep 2026

Development and Validation of an Interpretable Prediction Model for IVIG-Resistant Kawasaki Disease: A Multicenter Prospective Cohort Study.

An interpretable machine-learning model for early prediction of intravenous immunoglobulin-resistant Kawasaki disease and Shapley Additive Explanations-based interpretation and web deployment may facilitate individualized risk assessment and clinical decision-making.

Shu-Hui Wang, Zhi-Yuan Liu, Miao Hou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.